https://www.pharmaradar360.com/article/ec9b9b7cb53bef0cPharmaRadar360en2026-05-08T10:59:00.000ZBristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adultshttps://www.pharmaradar360.com/article/1830780ebaff6633PharmaRadar360en2026-05-08T09:00:00.000Zはしる図書館「日本新薬きらきら未来ゴー！」（2025年度 活動報告）https://www.pharmaradar360.com/article/1cf409cc047dccc1PharmaRadar360en2026-05-08T00:00:00.000Znatco records %e2%82%b9705 4 crore consolidated revenue and %e2%82%b9151 3 crore of profit after tax for q3fy26https://www.pharmaradar360.com/article/07a3fe729022daa7PharmaRadar360en2026-05-08T00:00:00.000Znatco records %e2%82%b91463 crore consolidated revenue and %e2%82%b9517 9 crore of profit after tax for q2fy26https://www.pharmaradar360.com/article/6e9bc12e75e8be23PharmaRadar360en2026-05-08T00:00:00.000Znatco receives tentative approval for erdafitinib tablets generic of balversa from the united states food and drug administration u s fdahttps://www.pharmaradar360.com/article/aadd375e17dc5f35PharmaRadar360en2026-05-08T00:00:00.000Znatco receives approval from central drug standard control organisation cdsco for semaglutide in indiahttps://www.pharmaradar360.com/article/4829157a4994d8d8PharmaRadar360en2026-05-08T00:00:00.000Znatco pharma limited api unit in chennai receives establishment inspection report eir from u s fdahttps://www.pharmaradar360.com/article/c98848c9f8b3c4f3PharmaRadar360en2026-05-08T00:00:00.000Znatco pharma launches semaglutide generic injection multi dose vials in india at the most affordable price starting from mrp inr 1290https://www.pharmaradar360.com/article/1e2a6ebbba598443PharmaRadar360en2026-05-08T00:00:00.000Znatco announces launch of pomalidomide capsules generic of pomalyst in the u s markethttps://www.pharmaradar360.com/article/146d0e8c41f62281PharmaRadar360en2026-05-08T00:00:00.000Znatco announces launch of its everolimus tablets 1 mg generic of zortresshttps://www.pharmaradar360.com/article/64b602742fff213ePharmaRadar360en2026-05-08T00:00:00.000Zlegal update regarding risdiplamhttps://www.pharmaradar360.com/article/0d9b980c99a81bb7PharmaRadar360en2026-05-08T00:00:00.000Zintimation under regulation 30 of sebi listing obligations and disclosure requirements regulations 2015 2https://www.pharmaradar360.com/article/6d748aab325d9256PharmaRadar360en2026-05-08T00:00:00.000Zdisclosure under regulation 30 of the sebi listing obligations and disclosure requirements regulations 2015https://www.pharmaradar360.com/article/36bd9f9fb465fc36PharmaRadar360en2026-05-08T00:00:00.000Zadcock ingram completes delisting from jse natco pharma acquires 35 75 stakehttps://www.pharmaradar360.com/article/ba0ffcfda51c88d7PharmaRadar360en2026-05-08T00:00:00.000Z6203https://www.pharmaradar360.com/article/7d73d3bfa5226f1dPharmaRadar360en2026-05-08T00:00:00.000ZHome pagehttps://www.pharmaradar360.com/article/6fa82f108a18256cPharmaRadar360en2026-05-07T23:01:51.000ZImproved early warning systems needed to reduce medicines supply risks, says ABPIhttps://www.pharmaradar360.com/article/036ec3e21cf16d55PharmaRadar360en2026-05-07T20:07:37.000ZZymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Resultshttps://www.pharmaradar360.com/article/46dff3e35186caf7PharmaRadar360en2026-05-07T20:05:00.000ZCodexis Reports First Quarter 2026 Financial Resultshttps://www.pharmaradar360.com/article/b82f1c0d93320182PharmaRadar360en2026-05-07T20:01:00.000ZAmneal Reports First Quarter 2026 Financial Resultshttps://www.pharmaradar360.com/article/782379e87d85d717PharmaRadar360en2026-05-07T18:05:00.000ZMerck Scientists Publish Landmark Paper on Novel Method for Large-Scale Biocatalytic Synthesis of Investigational Oral PCSK9 Inhibitor, Enlicitide Decanoatehttps://www.pharmaradar360.com/article/1fe692190ab206a0PharmaRadar360en2026-05-07T17:13:19.000ZFind product information about medicineshttps://www.pharmaradar360.com/article/070a20cb4fa9376fPharmaRadar360en2026-05-07T15:43:50.000ZCurso básico para Regentes de Laboratorio Clínicohttps://www.pharmaradar360.com/article/8240bbf8f43a92f2PharmaRadar360en2026-05-07T15:27:53.000ZResearch Rising: A Commitment to Advancing Human Lifehttps://www.pharmaradar360.com/article/520bad08d8a382b6PharmaRadar360en2026-05-07T15:08:03.000ZData et prospective - Economie du médicament 2025https://www.pharmaradar360.com/article/1d45fec8ce825840PharmaRadar360en2026-05-07T15:03:45.000ZLa AEMPS informa de un retraso en el restablecimiento de Tranxilium 20 mg polvo y disolvente para solución inyectablehttps://www.pharmaradar360.com/article/19bb703cf850bed7PharmaRadar360en2026-05-07T14:11:37.000ZGuidance: RSV Vaccine Factsheet – Information for Patients, Parents and Carershttps://www.pharmaradar360.com/article/18cc2c28428f5ed5PharmaRadar360en2026-05-07T13:01:25.000ZeXoZymes Announces Graduation from Shell GameChanger™ Accelerator Powered by NLR (GCxN) Programhttps://www.pharmaradar360.com/article/d655dd8ba918c175PharmaRadar360en2026-05-07T13:00:00.000ZInnocare Pharma’s ICP-B208 gains IND clearance in Chinahttps://www.pharmaradar360.com/article/7568a192a69baf1fPharmaRadar360en2026-05-07T12:36:21.000ZDecision: Orphan registered medicinal productshttps://www.pharmaradar360.com/article/7dd6b13f609e7611PharmaRadar360en2026-05-07T12:35:48.000ZDecision: Human medicines: register of licensed wholesale distribution siteshttps://www.pharmaradar360.com/article/077f421f61888820PharmaRadar360en2026-05-07T12:35:21.000ZDecision: Human and veterinary medicines: register of licensed manufacturing siteshttps://www.pharmaradar360.com/article/a635bd84e47c5ebaPharmaRadar360en2026-05-07T12:35:07.000ZDecision: Medicines: new manufacturing and wholesale dealer licenceshttps://www.pharmaradar360.com/article/353babd83f7852e7PharmaRadar360en2026-05-07T12:34:56.000ZNotice: Register of brokers authorised to deal in human medicineshttps://www.pharmaradar360.com/article/48e483575cd7354ePharmaRadar360en2026-05-07T12:34:34.000ZNotice: Medicines: terminated and cancelled manufacturing and wholesale dealer licenceshttps://www.pharmaradar360.com/article/35ac4009636c94dfPharmaRadar360en2026-05-07T09:44:00.000ZThe Danish Medicines Agency will be closed on Friday 15 May 2026https://www.pharmaradar360.com/article/f703dd2134e88db7PharmaRadar360en2026-05-07T09:38:57.000ZΑνάκληση των παρτίδων 20256508 και 202510501 των ιατροτεχνολογικών προϊόντων δοχεία συλλογής αίματος Lab tub Blood Collections Tubes 9NC Sodium Citrate, 13X75mm, 4mlhttps://www.pharmaradar360.com/article/3598afd6ecee704dPharmaRadar360en2026-05-07T09:35:21.000ZΑνάκληση της παρτίδας 25F1340 (exp date 12/2026) του ιατροτεχνολογικού προϊόντος δοχεία συλλογής αίματος VACUMED with K2 EDTA 16.2 mg Blood Collections Tubes 16X100 mm, 9ml (μωβ πώμα)https://www.pharmaradar360.com/article/080c22ea8c9f0b8dPharmaRadar360en2026-05-07T09:17:00.000ZOperation Pangea XVIII: Global action against falsified medicines and illicit tradehttps://www.pharmaradar360.com/article/6485a7b12ebe7ea9PharmaRadar360en2026-05-07T06:50:44.000ZΑπαγόρευση διακίνησης και διάθεσης του προϊόντος ASEPTOMAN GELhttps://www.pharmaradar360.com/article/382c1fda54d84a5aPharmaRadar360en2026-05-07T05:00:00.000ZRoche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics